ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceride-rich lipoproteins

J Lipid Res. 2012 Apr;53(4):736-43. doi: 10.1194/jlr.M019992. Epub 2012 Jan 18.

Abstract

Although the evidence linking apoA-IV expression and triglyceride (TG)-rich lipoprotein assembly and secretion is compelling, the intracellular mechanisms by which apoA-IV could modulate these processes remain poorly understood. We therefore examined the functional impact of apoA-IV expression on endogenous apoB, TG, and VLDL secretion in stably transfected McA-RH7777 rat hepatoma cells. Expression of apoA-IV modified with the endoplasmic reticulum (ER) retention signal KDEL (apoA-IV-KDEL) dramatically decreased both the rate and efficiency of endogenous apoB secretion, suggesting a presecretory interaction between apoA-IV-KDEL and apoB or apoB-containing lipoproteins. Expression of native apoA-IV using either a constitutive or tetracycline-inducible promoter delayed the initial rate of apoB secretion and reduced the final secretion efficiency by ∼40%. However, whereas apoA-IV-KDEL reduced TG secretion by 75%, expression of native apoA-IV caused a 20-35% increase in TG secretion, accompanied by a ∼55% increase in VLDL-associated apoB, an increase in the TG:phospholipid ratio of secreted d < 1.006 lipoproteins, and a 10.1 nm increase in peak VLDL(1) particle diameter. Native apoA-IV expression had a negligible impact on expression of the MTP gene. These data suggest that by interacting with apoB in the secretory pathway, apoA-IV alters the trafficking kinetics of apoB-containing TG-rich lipoproteins through cellular lipidation compartments, which in turn, enhances particle expansion and increases TG secretion.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apolipoproteins A / genetics
  • Apolipoproteins A / metabolism*
  • Apolipoproteins B / metabolism*
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Cell Line, Tumor
  • Culture Media / metabolism
  • Doxycycline / pharmacology
  • Gene Expression Regulation
  • Humans
  • Immunoprecipitation
  • Lipid Metabolism
  • Lipoproteins, VLDL / metabolism*
  • Promoter Regions, Genetic
  • Protein Transport
  • Rats
  • Tetracycline / pharmacology
  • Transfection
  • Triglycerides / metabolism*

Substances

  • Apolipoproteins A
  • Apolipoproteins B
  • Carrier Proteins
  • Culture Media
  • Lipoproteins, VLDL
  • Triglycerides
  • apolipoprotein A-IV
  • microsomal triglyceride transfer protein
  • Tetracycline
  • Doxycycline